![Page 1: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/1.jpg)
IMPROVING CONSUMER INTERFACE OF PHARMACEUTICAL & PRIVATE HEALTHCARE
CHIRANTAN CHATTERJEE (IIM-BANGALORE)
DEC 5TH 2013IIMB-CUTS CAPACITY BUILDING WORKSHOP IN PHARMA/HEALTHCARE
![Page 2: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/2.jpg)
2
Indian Pharma-Industry is @ a Cross-Road
![Page 3: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/3.jpg)
3
Indian Pharma-Industry is @ a Cross-Road
Extracts from a recent conversation with a friend
XYZ: playing the balancing gameIndian pharma doesn't look very conducive to consulting right now
29/11/2013 19:17Chirantan Chatterjee why do you say so?
29/11/2013 19:50XYZ: struggling to break through - thats why...
29/11/2013 21:19Chirantan Chatterjee unclear yet..but what happened 'right now' - such that
'breaking through' is becoming difficult...maybe i can offer some suggestions..Saturday
30/11/2013 11:59XYZ: what will sell now, is GMP remedial services... to get the vilified facilities
approved by USFDA and warnings removed - not our cup of tea
![Page 4: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/4.jpg)
4
So why is London Bridge Falling Down?
My argument is because:
We are callous about our own public health, charity after all begins at home. “Why is it acceptable for us to have a very qualified and extremely competent Governor of
the Reserve Bank of India, an institution that oversees monetary policy and not for the
institution that is responsible for public health of a country of over a billion people? Is public
health not half as important as fiscal health for us? “
3 standards for ‘regulated’ / ‘semi-regulated’/ ‘domestic markets’ – why?
Perennially seduced by the ‘jugaad attitude’.
Absence of evidence-based regulation: “Do we have any data that tells us how many times a particular prescription has been
changed because of drug-drug interactions? Many of our elderly take more than one drug
today, perhaps one for controlling their blood pressure, another one to control their sugar
levels and perhaps a third one for their arthritis. We have no data to assess how these
formulations (remember, I am saying formulations, manufactured according to the
standards for “less regulated” markets) behave in our patient population. “
![Page 5: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/5.jpg)
5
Could Consumers Change the Status-Quo? – Global Examples
Public health outreach ala CDC-US for flu-shots.
Use Social Media – Check out www.patientslikeme.com.
Regulators could educate consumers – NICE in UK great
example: www.nice.org.uk
Could the Mediplus-es of the world play a role ala
Walmart/CVS? http://
www.walgreens.com/health/health_info.jsp
How about Providers?
http://www.mayoclinic.com/health-information/
Some upcoming examples www.reviews42.com but not nearly
enough.
![Page 6: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/6.jpg)
6
Pharmaceutical Trojans in our communities?
![Page 7: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/7.jpg)
7
E-Governance & Good Work by Some State-FDCAs, Notably Gujarat
Web Portal Link
FDCA’s Web site http://gujhealth.gov.in/food_drug
Sales License Software http://xlnfda.guj.nic.in
Manufacturing License Software – For Manufacturer http://idmla.guj.nic.in
Manufacturing License Software – For FDCA Officers http://dmla.guj.nic.in
Online Complaint Module http://gujhealth.gov.in/complaint
![Page 8: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/8.jpg)
Transparent & hassle free procedures
SMS intim
ation
Hassle free pro
cedureNo chance of
corrupt practices
SMS-Based Drug Recall System – Working Great
![Page 9: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/9.jpg)
SMS Alerts
Effectiv
e recall
Benefits to Business Community
SMS-Based Drug Recall System – Working Great
![Page 10: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/10.jpg)
Mobile Testing Labs
![Page 11: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/11.jpg)
11
Peer Effects Created on Other States
XLN – GUJARAT MODELOPERATIONAL
PROPOSED
XLN – GUJARAT MODELTOTAL
6 + 6 = 12 STATES COVERING MORE THAN 65% AREA OF COUNTRY
Other States intergration
![Page 12: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/12.jpg)
12
CDSCO Has an Important Role to Play
When is the next report coming out please?
![Page 13: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/13.jpg)
13
Whistle Blower Schemes – Need to Be Sharpened
![Page 14: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/14.jpg)
14
Differences Across Regions – Need to be Minimized
Bhaskarabhatla, Chatterjee & Karreman (2013)
![Page 15: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/15.jpg)
15
Differences Across Regions – Need to be Minimized
Who Will Bell the Cat?
![Page 16: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/16.jpg)
16
Residual aspects
Cocktail drugs & their prescribing behavior needs oversight.
The Role of Oversight on Pharmaceutical Promotions? Role of
IMA
The Key Role of State-Owned Public Sector Units to create
benchmark Quality standards.
Medical devices continue sales unmonitored.
Price dispersion in healthcare services:
The same knee-replacement surgery in a city could vary in
prices but is that price a signal of quality?
What rights do we have to demand information on quality?
![Page 17: Quality (not dirty) medicines - The Way Ahead for Indian Pharma](https://reader033.vdocument.in/reader033/viewer/2022052315/55738059d8b42af4698b51e6/html5/thumbnails/17.jpg)
17
Departing Remarks
How long are we going to be afraid to look at what is
wrong?
A true patriot says “we can do better”; a false patriot on
the other hand says “we are good enough”.
We need to move to ‘Quality Medicines’ – not ‘Dirty
Medicines’.
Thank you.